Drug recall · December 26, 2012
Lidocaine HCl Injection recall
Why: Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.
- Lots / codes
Lot #: 14-277-DK*, Exp 02/01/14; * may be followed by 01
- Quantity
- 120,350 vials
- Company
- Hospira, Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- October 4, 2012 · Voluntary: Firm initiated
- Classified
- December 20, 2012
- Reported
- December 26, 2012
- Ended
- May 8, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.